Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing. (2017)

First Author: Van Der Ree MH
Attributed to:  Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2017.08.016

PubMed Identifier: 28844749

Publication URI: http://europepmc.org/abstract/MED/28844749

Type: Journal Article/Review

Volume: 146

Parent Publication: Antiviral research

ISSN: 0166-3542